1-2 of 2
Keywords: chronic hepatitis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma

Available to Purchase
Michiko OKUBO, Goshi SHIOTA, Hironaka KAWASAKI
Journal: Clinical Science
Clin Sci (Lond) (2000) 99 (3): 207–214.
https://doi.org/10.1042/cs0990207
Published: 03 August 2000
... for thrombocytopenia in liver diseases. To address this issue, we measured serum TPO, using a sensitive sandwich ELISA, in 108 patients with chronic viral hepatitis, which included chronic hepatitis (CH) and liver cirrhosis (LC), and hepatocellular carcinoma (HCC), and in 29 normal controls. TPO mRNA in 78 liver...
View articletitled, Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma
Open the PDF for Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma in another window
Articles

Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage

Available to Purchase
Giovambattista DESIDERI, Claudio FERRI
Journal: Clinical Science
Clin Sci (Lond) (2000) 99 (2): 159–160.
https://doi.org/10.1042/cs0990159
Published: 17 July 2000
...Giovambattista DESIDERI; Claudio FERRI Correspondence : Dr G Desideri (e-mail [email protected] ). 13 12 1999 The Biochemical Society and the Medical Research Society © 2000 2000 chronic hepatitis cirrhosis vascular endothelial growth factor 159Clinical Science (2000...
View articletitled, Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage
Open the PDF for Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage in another window